The earnings call reveals several concerns: high dependency on retail relationships, elevated costs for expansion, and declining financial metrics, including a gross profit loss and increased SG&A expenses. While there are positive elements such as the USDA Organic herb program and potential growth in CPG products, the lack of specific guidance on CapEx and the need for margin recovery by 2026 raise uncertainties. The Q&A section highlighted management's reluctance to provide detailed financial clarity, further contributing to a negative sentiment.